L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA

European Journal of Neuroscience

Volumn 10, Issue 8, 1998, Pages 2694-2706

  Cenci, M A ^a   Lee, C S ^a,b   Bjorklund A ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Dynorphin; Enkephalin; Neuropeptide; Parkinson's disease; Substance P

Indexed keywords

GLUTAMATE DECARBOXYLASE; LEVODOPA; MESSENGER RNA; OXIDOPAMINE; PREPROENKEPHALIN; PREPROTACHYKININ; PRODYNORPHIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DYSKINESIA; FEMALE; GLOBUS PALLIDUS; IN SITU HYBRIDIZATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AUTORADIOGRAPHY; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DYSKINESIA, DRUG-INDUCED; ENKEPHALINS; FEMALE; GENE EXPRESSION REGULATION; GLUTAMATE DECARBOXYLASE; IN SITU HYBRIDIZATION; LEVODOPA; OXIDOPAMINE; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RNA, MESSENGER; TACHYKININS;

EID: 0031925945     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.1998.00285.x     Document Type: Article

References (12)

1. Abercrombie, E.D., Bonatz, A.E. & Zigmond, M.J. (1990) Effects of L-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine treated rats. Brain Res., 525, 36-44.
2. Albin, R.L., Young, A.B. & Penney, J.B. (1989) The functional anatomy of basal ganglia disorders. Trends. Neurosci., 12, 366-375.
3. Andrén, P.E., Bennmarker, R. & Gunne, L.M. (1997) Naloxone reduces levodopa-induced dyskinesias in the MPTP-treated common marmosets. Soc. Neurosci. Abs. 738.12., 23, 1902.
4. Augood, S.J., Emson, P.C., Mitchell, I.J., Boyce, S., Clarke, C.E. & Crossman, A.R. (1989) Cellular localisation of enkephalin gene expression in MPTP-treated cynomolgus monkey. Mol. Brain Res., 6, 85-92.
5. Bédard, P.J., Gomez Mancilla, B., Blanchette, P., Gagnon, C. & Di Paolo, T. (1992) Levodopa-induced dyskinesia: facts and fancy. What does the MPTP monkey model tell us? Can. J. Neurol. Sci., 19, 134-137.
6. Bolam, J.P., Smith, Y., Ingham, C.A., von Krosigk, M. & Smith, A.D. (1993) Convergence of synaptic terminals from the striatum and the globus pallidus onto single neurones in the substantia nigra and the entopeduncular nucleus. In Arbuthnott, G.W. & Emson, P.C. (eds), Progress in Brain Research, Vol. 99, Elsevier Science B.V., Amsterdam, pp. 73-88.
7. Boyce, S., Rupniak, N.M.J., Steventon, M.J. & Iversen, S.D. (1990) Characterization of dyskinesias induced by L-DOPA in MPTP-treated squirrel monkeys. Psychopharmacology, 102, 21-27.
8. Carey, R.J. (1991a) Chronic L-DOPA treatment in the unilateral 6-OHDA rat: evidence for behavioral sensitization and biochemical tolerance. Brain Res., 568, 205-214.
9. Carey, R.J. (1991b) Naloxone reverses L-DOPA induced overstimulation effects in a Parkinson's disease animal model analogue. Life Sci., 48, 1303-1308.
10. Cenci, M.A., Campbell, K. & Björklund, A. (1993) Neuropeptide messenger RNA expression in the 6-hydroxydopamine lesioned rat striatum reinnervated by fetal dopaminergic transplants: differential effects of the grafts on preproenkephalin, preprotachykinin, and prodynorphin messenger RNA levels. Neuroscience, 57, 275-296.
11. Cenci, M.A., Campbell, K. & Björklund, A. (1997) Glutamic acid decarboxylase gene expression in the dopamine-denervated striatum: effects of fetal nigral grafts or chronic apomorphine treatment. Mol. Brain Res., 48, 149-155.
12. Cenci, M.A., Lee, C.S. & Björklund, A. (1996) A rat model of levodopa-induced dyskinesia: neurochemical changes in the basal ganglia and effects of intrastriatal dopamine-rich transplants. Soc. Neurosci. Abs. 592.5., 22, 1491.